Work

Influence of concurrent medications on PSA doubling time (PSADT) in patients (pts) with nonmetastatic biochemically relapsed prostate cancer (BRPC M0) after local therapy (tx).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.160

Authors: Daniel Keizman, Maya Ish-Shalom, Natalie Maimon, Maya Gottfried, Keren Roubinov, Roberto Pili, Victoria J. Sinibaldi, Hans J. Hammers, Michael Anthony Carducci, Mario A. Eisenberger, Wilmosh Mermershtain

Institutions: Tel Aviv University, Meir Medical Center, Soroka Medical Center, Roswell Park Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4240813958

Cites:

Cited by:

Related to: 10